White Paper

Biopharmaceutical Intellectual Property Disputes

Chemical composition often is at the root of patent disputes between drug companies. Analytical chemistry analysis is of the utmost importance to identify slight variations (or lack thereof) in chemical composition between products.

This white paper reviews the fundamentals of drug development and intellectual property disputes, demonstrating the important role analytical chemistry plays in biopharmaceutical product development.

To learn more about how Element can help you in intellectual property disputes, download the free white paper below.

Biopharmaceutical Intellectual Property Disputes includes discussion on

  • New drug development for generics and name brand pharmaceuticals
  • The Hatch-Waxman Amendment
  • The differences between pharmaceuticals and biopharmaceuticals
  • The role chemical analysis plays in intellectual property disputes

View more articles about

Find related articles to you through the Nucleus